PFIZER INC — Director's Dealing 2022

Jun 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2022-05-31

Reporting Person: Denton David M (Chief Financial Officer & EVP)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-31	Common Stock	A	61275.0000	$0.0000	Acquired	62165.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-31	Stock Appreciation Rights	$53.0400	A	80703.0000	Acquired	2027-05-31	Common Stock (80703.0000)	Direct
2022-05-31	Stock Appreciation Rights	$53.0400	A	70313.0000	Acquired	2029-05-31	Common Stock (70313.0000)	Direct

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.